The Scientist

» diagnostics and immunology

Most Recent

image: Single Antibody Protects Macaques from Ebola

Single Antibody Protects Macaques from Ebola

By | February 25, 2016

The “just right” binding properties of a monoclonal antibody from an Ebolavirus survivor help it neutralize the virus.

0 Comments

image: Anti-Inflammatory Drugs as Antivenom?

Anti-Inflammatory Drugs as Antivenom?

By | February 24, 2016

Compounds typically used to calm the immune system can prevent death from scorpion venom in mice, researchers report.

0 Comments

image: Detecting Lyme Early

Detecting Lyme Early

By | February 12, 2016

Two new methods could help researchers to diagnose Lyme disease earlier than with existing tests.

0 Comments

image: Premature Assault?

Premature Assault?

By | February 9, 2016

Plants may trick bacteria into attacking before the microbial population reaches a critical size, allowing the plants to successfully defend the weak invasion.

0 Comments

image: Additional Zika Tests in Development

Additional Zika Tests in Development

By | February 3, 2016

Scientists design diagnostics to improve the detection of current infections.

0 Comments

image: Abbott Acquires Diagnostics Firm

Abbott Acquires Diagnostics Firm

By | February 2, 2016

In a deal worth $5.8 billion, Abbott Laboratories is buying medical test–maker Alere.

0 Comments

image: Zika Update

Zika Update

By | February 1, 2016

Link to microcephaly questioned; vaccine timeline expedited; thousands of Zika-exposed pregnancies reported in Colombia

0 Comments

image: Contributors

Contributors

By | February 1, 2016

Meet some of the people featured in the February 2016 issue of The Scientist.

0 Comments

image: Fungal Security Force

Fungal Security Force

By | February 1, 2016

In yew trees, Taxol-producing fungi function as an immune system to ward off pathogens.

0 Comments

image: Holding Their Ground

Holding Their Ground

By | February 1, 2016

To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

1 Comment

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham